Skip to main content
Log in

Gemcitabine-associated diffuse alveolar hemorrhage

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Aapro MS, Martin C, Hatty S (1998) Gemcitabine - a safety rewiew. Anticancer Drugs 9: 191–201

    Article  CAS  PubMed  Google Scholar 

  2. Green RJ, Ruoss SJ, Kraft SA, Berry GJ, Raffin TA (1996) Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 110: 1305–1316

    Article  CAS  PubMed  Google Scholar 

  3. Pavlakis N, Bell DR, Millward MJ, et al (1997) Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer 80: 286–291

    Article  CAS  PubMed  Google Scholar 

  4. Marruchella A, Fiorenzano G, Merizzi A, et al (1998) Diffuse alveolar damage in a patient treated with gemcitabine. Eur Respir 111: 504–506

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carron, PL., Cousin, L., Caps, T. et al. Gemcitabine-associated diffuse alveolar hemorrhage. Intensive Care Med 27, 1554 (2001). https://doi.org/10.1007/s001340101037

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001340101037

Navigation